B50

4-(4-chlorophenyl)-1-[(3S)-3,4-dihydroxybutyl]-N-[3-(4-methylpiperazin-1-yl)propyl]-3-phenyl-1H-pyrrole-2-carboxamide

Created:	2011-07-07
Last modified:	2011-07-07

Find Related PDB Entry
1 entries where B50 is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	74
Chiral Atom Count	1
Bond Count	77
Aromatic Bond Count	17

2D diagram of B50

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	4-(4-chlorophenyl)-1-[(3S)-3,4-dihydroxybutyl]-N-[3-(4-methylpiperazin-1-yl)propyl]-3-phenyl-1H-pyrrole-2-carboxamide
Systematic Name (OpenEye OEToolkits)	1-[(3S)-3,4-bis(oxidanyl)butyl]-4-(4-chlorophenyl)-N-[3-(4-methylpiperazin-1-yl)propyl]-3-phenyl-pyrrole-2-carboxamide
Formula	C₂₉ H₃₇ Cl N₄ O₃
Molecular Weight	525.082
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	Clc1ccc(cc1)c3c(c2ccccc2)c(n(c3)CCC(O)CO)C(=O)NCCCN4CCN(CC4)C
SMILES	CACTVS	3.370	CN1CCN(CCCNC(=O)c2n(CC[CH](O)CO)cc(c3ccc(Cl)cc3)c2c4ccccc4)CC1
SMILES	OpenEye OEToolkits	1.7.2	CN1CCN(CC1)CCCNC(=O)c2c(c(cn2CCC(CO)O)c3ccc(cc3)Cl)c4ccccc4
Canonical SMILES	CACTVS	3.370	CN1CCN(CCCNC(=O)c2n(CC[C@H](O)CO)cc(c3ccc(Cl)cc3)c2c4ccccc4)CC1
Canonical SMILES	OpenEye OEToolkits	1.7.2	CN1CCN(CC1)CCCNC(=O)c2c(c(cn2CC[C@@H](CO)O)c3ccc(cc3)Cl)c4ccccc4
InChI	InChI	1.03	InChI=1S/C29H37ClN4O3/c1-32-16-18-33(19-17-32)14-5-13-31-29(37)28-27(23-6-3-2-4-7-23)26(22-8-10-24(30)11-9-22)20-34(28)15-12-25(36)21-35/h2-4,6-11,20,25,35-36H,5,12-19,21H2,1H3,(H,31,37)/t25-/m0/s1
InChIKey	InChI	1.03	DXJMWRCEEVNUJU-VWLOTQADSA-N

Related Resource References

Resource Name	Reference
PubChem	57339126
ChEMBL	CHEMBL2063880

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.